VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Nov 19, 2024 10:49pm

43 Views

Post# 36320957

RE:👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀

This is indeed very encouraging. I am puzzled though, why didn't they include Mayo clinic in the NR? IMO just the mention of Mayo Clinic and their initial purchase would cause a market reaction. So, does anybody know why Mayo not mentioned in NR? I only see it in Dr. George Adams letter....

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project